Novel Anticoagulants

0:01:08

AME Minute: New Oral Anticoagulants in the DVT Protocol

0:03:01

Novel Anticoagulants by Jeffery A. Betcher, RPh | Preview

0:04:30

Cardiology Countdown | Biomarkers and Novel Anticoagulants by CHADS2 Risk Score

1:05:13

12 Oral Anticoagulation Therapy and Practical Use of Novel Anticoagulants

0:06:49

News Archive | Novel Anticoagulants in the Caribbean

0:11:26

Novel Anticoagulants :: Jeffrey I. Weitz, MD :: Part 2 of 2

0:12:00

Heparin vs. Warfarin - Anticoagulants - Blood thinners - Hematology - Pharmacology

0:05:45

News Archive | Novel Anticoagulants in South Africa

0:53:56

Novel Anticoagulants Part 2, unique challenges associated with them in the cardiac surgery patient

0:50:25

Peri-operative management of anticoagulation

1:05:13

12 Oral Anticoagulation Therapy and Practical Use of Novel Anticoagulants

0:06:13

News Archive | Novel Anticoagulants in Europe

0:02:54

Disadvantages of Novel Oral Anticoagulants Compared with Vitamin K Antagonists

0:18:20

Emergency Operations and the new Anticoagulants: What to Do?

0:12:09

Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran

0:09:33

AF Action Initiative Interview: Dr. Piazza compares Novel Oral Anticoagulants

0:30:46

NOACs fact and fiction

0:01:51

How Pharmacists Can Improve Adherence to Novel Oral Anticoagulants

0:09:03

News Archive | Novel Anticoagulants in Canada and the US

0:01:41

Advantages of Novel Oral Anticoagulants Over Vitamin K Antagonists

0:25:00

E. Baryshnikova - Novel anticoagulants and antiplatelet agents: what to look for in daily practice?

0:01:31

Remembering the Novel Oral AntiCoagulants (NOACs)

0:42:48

NOAC (Novel Oral Anticoagulants)